Product image of Nelibat (Atorvastatin) supplied by GNH India

Nelibat

Active Ingredient:
Atorvastatin
Origin:
EU

Nelibat (Atorvastatin)

Atorvastatin, the active ingredient in Nelibat, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol and triglyceride levels and is used in adults with hypercholesterolemia, mixed dyslipidemia, or at risk of cardiovascular events.

GNH India supplies Nelibat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Manufacturer / TM Owner

Libytec Pharmaceutical S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nelibat (atorvastatin) is indicated for disorders of lipid metabolism and for reducing cardiovascular risk.

  • Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol and total cholesterol levels.
  • Mixed dyslipidemia: lowers triglycerides and raises high‑density lipoprotein (HDL) cholesterol.
  • Cardiovascular risk reduction: helps prevent myocardial infarction, stroke and other atherosclerotic events in patients with established risk factors.

How It Works

  • Atorvastatin competitively inhibits HMG‑CoA reductase, the key enzyme in hepatic cholesterol biosynthesis. This inhibition decreases intracellular cholesterol, prompting up‑regulation of LDL receptors on hepatocyte surfaces, which enhances clearance of circulating LDL particles and modestly lowers triglycerides while modestly raising HDL cholesterol.

Side Effects

Atorvastatin may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Myalgia: muscle aches without weakness.
  • Abdominal pain: discomfort in the stomach area.
  • Nausea: feeling of queasiness.
  • Constipation: reduced bowel movements.
  • Elevated liver enzymes: mild increase in transaminases.

Serious or Rare Side Effects

  • Rhabdomyolysis: severe muscle breakdown with risk of renal failure.
  • Severe liver injury: marked elevation of hepatic enzymes or hepatitis.
  • Allergic reactions: rash, angioedema, or anaphylaxis.
  • Pancreatitis: inflammation of the pancreas.
  • Myopathy with CK elevation: muscle weakness with high creatine kinase.
  • Hepatitis: inflammation of the liver.

Precautions & Warnings

When prescribing Nelibat, clinicians should consider several safety and handling precautions.

  • Liver function monitoring: assess baseline transaminases and repeat periodically.
  • Muscle toxicity vigilance: discontinue if unexplained muscle pain, weakness or CK elevation occurs.
  • Drug interactions: review concomitant medications that may increase statin levels.
  • Pregnancy and lactation: contraindicated in pregnancy (Category X) and not recommended while breastfeeding.
  • Renal or hepatic impairment: dose adjustment may be required in severe disease.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Avoid Interactions

Atorvastatin interacts with several medicines that can alter its plasma concentration or increase toxicity risk.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, HIV protease inhibitors, nefazodone, grapefruit juice).
  • Gemfibrozil or other fibrates: increased risk of myopathy.

Moderate Interactions (Monitor Closely)

  • Amiodarone: may raise atorvastatin levels.
  • Digoxin: potential for increased serum concentrations.
  • Warfarin: may enhance anticoagulant effect.
  • Cyclosporine: can increase statin exposure.
  • Niacin: higher incidence of muscle toxicity.

Frequently Asked Questions

Nelibat contains atorvastatin, a statin medication prescribed to lower elevated cholesterol and triglyceride levels. It is used in adults with hypercholesterolemia, mixed dyslipidemia, and in patients who have risk factors for cardiovascular events such as heart attack or stroke.

Atorvastatin blocks the enzyme HMG‑CoA reductase, which is essential for the liver to produce cholesterol. By reducing cholesterol synthesis, the drug increases the number of LDL receptors on liver cells, enhancing removal of LDL cholesterol from the bloodstream and improving overall lipid profiles.

The appropriate dose of Nelibat is determined by the prescribing healthcare professional based on the patient’s lipid levels, overall cardiovascular risk, and tolerance. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their prescriber.

Nelibat is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because of potential fetal harm. It is also not recommended for breastfeeding mothers, as atorvastatin can be excreted in breast milk and may affect the infant.

To order Nelibat, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nelibat (atorvastatin) is a high‑potency statin that typically provides greater LDL‑cholesterol reduction than lower‑intensity agents such as pravastatin or lovastatin. Its pharmacokinetic profile allows once‑daily dosing, and it has a well‑studied safety record, though like all statins it shares common class‑related risks such as muscle effects.

Nelibat tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Nelibat is taken orally, usually once daily, with or without food as directed by the prescriber. The tablet should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse events associated with Nelibat include rhabdomyolysis (severe muscle breakdown), significant liver injury, and rare allergic reactions such as angioedema. Patients should report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction such as jaundice promptly.

Nelibat should not be used by individuals with active liver disease, unexplained persistent elevations of hepatic enzymes, or a known hypersensitivity to atorvastatin or any tablet excipients. It is also contraindicated in pregnant women, nursing mothers, and patients taking certain strong CYP3A4 inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Atorvastatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT